Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Membranous Nephropathy

Manuel Alfredo Podestà; Valentina Portalupi; Alessia Gennarini; Alessandro Villa; Nadia Rubis; Giuseppe Remuzzi; Piero Ruggenenti

doi:10.1681/asn.20223311s1183a

Related publications

Article2023

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series

Manuel Alfredo Podestà, Matias Trillini, Valentina Portalupi, Alessia Gennarini, Federica Tomatis, Alessandro Villa, Annalisa Perna, Nadia Rubis, Giuseppe Remuzzi, Piero Ruggenenti

Article2020

Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness

Manuel Alfredo Podestà, Barbara Ruggiero, Giuseppe Remuzzi, Piero Ruggenenti

Article2021

Rituximab in Membranous Nephropathy

Jae Il Shin, Federico Alberici, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Kres̆imir Gales̃ić, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Harbir Singh Kohli, Gert Mayer, Rutger Maas, Sergey Moiseev, Ruth J. Pepper, Luís F. Quintana, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimı́r Tesař, Jack F.M. Wetzels, Lisa Willcocks, Ladan Zand, ,

Article2023

#5215 OFATUMUMAB AS A RESCUE THERAPY FOR PATIENTS WITH MEMBRANOUS NEPHROPATHY

Manuel Alfredo Podestà, Valentina Portalupi, Alessia Gennarini, Federica Tomatis, Alessandro Villa, Nadia Rubis, Giuseppe Remuzzi, Piero Ruggenenti

Article2012

Rituximab in Idiopathic Membranous Nephropathy

Piero Ruggenenti, Paolo Cravedi, Antonietta Chianca, Annalisa Perna, Barbara Ruggiero, Flavio Gaspari, Alessandro Rambaldi, Maddalena Marasà, Giuseppe Remuzzi